Abzena (ABZA)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 7.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 52.25
  • 52 Week Low: 7.75
  • Currency: UK Pounds
  • Shares Issued: 214.22m
  • Volume: 0
  • Market Cap: 16.60m
  • Beta: 0.04

Abzena Overview

Abzena is in the pharma and biotech sector and is currently trading at 7.75p per share. In the last year Abzena's share price has ranged from 7.75p to 52.25p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -68.1% -39.6%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.8 0.6
Pr/Book 0.4  
Latest F'cast
Revenue 17.7% 24.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Abzena Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-14 5.26 (4.10) (253.00)p n/a n/a n/a n/a 0.0%
31-Mar-15 5.67 (5.22) (7.00)p n/a n/a n/a n/a 0.0%
31-Mar-16 9.85 (10.66) (9.00)p n/a n/a n/a n/a 0.0%
31-Mar-17 18.65 (9.46) (7.00)p n/a n/a n/a n/a 0.0%
31-Mar-18 21.95 (14.75) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Abzena Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 27.31 (10.82) (4.81)p n/a n/a n/a n/a 0.0%
31-Mar-20 35.68 (6.96) (3.07)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Abzena Company Announcements

Blocklisting update 06-Jul-2018 15:55 RNS
Abzena and Telix sign manufacturing agreement 02-Jul-2018 07:00 RNS
Annual Report and Accounts 19-Jun-2018 12:28 RNS

Latest Abzena Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Abzena Market Data

Currency UK Pounds
Share Price 7.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 52.25
52 Week Low 7.75
Volume 0
Shares Issued 214.22m
Market Cap 16.60m
Beta 0.04

Abzena Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.33% above the market average50.33% above the market average50.33% above the market average50.33% above the market average50.33% above the market average
84.13% above the sector average84.13% above the sector average84.13% above the sector average84.13% above the sector average84.13% above the sector average
Price Trend
98.85% below the market average98.85% below the market average98.85% below the market average98.85% below the market average98.85% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
48.73% above the market average48.73% above the market average48.73% above the market average48.73% above the market average48.73% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abzena Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

Abzena Key Personnel

Chair Ken Cunningham
CEO John Burt
CFO Julian Smith

Top of Page